Prophylaxis for CMV should now replace pre-emptive therapy in solid organ transplantation (Q34191785)

31 July 2017

1 reference

title

Prophylaxis for CMV should now replace pre-emptive therapy in solid organ transplantation (English)

1 reference

31 July 2017

main subject

organ transplantation

1 reference

Hart GD

1

1 reference

31 July 2017

Paya CV

series ordinal

2

1 reference

31 July 2017

publication date

1 March 2001

1 reference

Reviews in Medical Virology

31 July 2017

published in

1 reference

31 July 2017

volume

11

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

73-81

1 reference

Cytomegalovirus disease and allograft loss after organ transplantation

31 July 2017

cites work

1 reference

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

21 January 2018

1 reference

Studies evaluating high-dose acyclovir, intravenous immune globulin, and cytomegalovirus hyperimmunoglobulin for prophylaxis against cytomegalovirus in kidney transplant recipients

21 January 2018

1 reference

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

21 January 2018

1 reference

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

21 January 2018

1 reference

A Randomized Prospective Trial of Acyclovir and Immune Globulin Prophylaxis in Liver Transplant Recipients Receiving OKT3 Therapy

21 January 2018

1 reference

Prediction and diagnosis of cytomegalovirus disease in renal transplant recipients using qualitative and quantitative polymerase chain reaction

21 January 2018

1 reference

Human herpesvirus-6 in transplantation: an emerging pathogen

21 January 2018

1 reference

Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus

21 January 2018

1 reference

Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy

21 January 2018

1 reference

Cytomegalovirus infections following renal transplantation – effects of antiviral prophylaxis: a report of the North American Pediatric Renal Transplant Cooperative Study

21 January 2018

1 reference

Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study

21 January 2018

1 reference

Comparison of the efficacy and cost effectiveness of pre-emptive therapy as directed by CMV antigenemia and prophylaxis with ganciclovir in lung transplant recipients

21 January 2018

1 reference

Failure of ganciclovir treatment associated with selection of a ganciclovir-resistant cytomegalovirus strain in a lung transplant recipient.

21 January 2018

1 reference

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

21 January 2018

1 reference

Long-term ganciclovir prophylaxis for successful prevention of primary cytomegalovirus (CMV) disease in CMV-seronegative liver transplant recipients with CMV-seropositive donors

21 January 2018

1 reference

Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation

21 January 2018

1 reference

Preemptive Therapy in Immunocompromised Hosts

21 January 2018

1 reference

Preemptive ganciclovir therapy in renal transplantation

21 January 2018

1 reference

Cytomegalovirus prophylaxis in solid organ transplant recipients

21 January 2018

1 reference

Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation: a meta-analysis

21 January 2018

1 reference

Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients

21 January 2018

1 reference

Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts

21 January 2018

1 reference

High-dose acyclovir prophylaxis reduces cytomegalovirus disease in liver transplant patients

21 January 2018

1 reference

Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database

21 January 2018

1 reference

A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients

21 January 2018

1 reference

Preemptive ganciclovir therapy in cytomegalovirus-seropositive renal transplants recipients

21 January 2018

1 reference

Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial

21 January 2018

1 reference

Prevention of cytomegalovirus-related death by passive immunization. A double-blind placebo-controlled study in kidney transplant recipients treated for rejection

21 January 2018

1 reference

Intravenous immunoglobulin infusions for the prophylaxis of secondary cytomegalovirus infection

21 January 2018

1 reference

High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial

21 January 2018

1 reference

Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients

21 January 2018

1 reference

Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients

21 January 2018

1 reference

The cost impact of cytomegalovirus disease in renal transplant recipients.

21 January 2018

1 reference

The economic impact of cytomegalovirus infection after liver transplantation

21 January 2018

1 reference

Ganciclovir susceptibilities of cytomegalovirus (CMV) isolates from solid organ transplant recipients with CMV viremia after antiviral prophylaxis

21 January 2018

1 reference

Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/RMV.309

1 reference

31 July 2017

1 reference